HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improvement in peripheral blood disease burden in patients with Sézary syndrome and leukemic mycosis fungoides after total skin electron beam therapy.

AbstractBACKGROUND:
There is a paucity of effective therapies for patients with Sézary syndrome and advanced mycosis fungoides with peripheral blood involvement. Total skin electron beam (TSEB) radiation therapy is an extremely effective skin-directed therapy for these patients, but, until recently, it was thought not to signifcantly affect the peripheral blood malignant T-cell population.
OBJECTIVE:
We conducted this study to determine if TSEB has therapeutic effect on the peripheral blood in patients with advanced mycosis fungoides and Sézary syndrome.
METHODS:
All patients on stable medication regimens seen in our photopheresis facility who received TSEB therapy between January 2008 and October 2011 at Temple University Hospital, Philadelphia, PA, were analyzed retrospectively for improvement in the peripheral blood, as documented by flow cytometry.
RESULTS:
Six of 11 patients achieved 50% or greater decrease in their peripheral blood malignant T-cell population after TSEB therapy, for an overall response rate of 55%. Within the group of patients who had a response in the skin, 67% also had a response in the peripheral blood.
LIMITATIONS:
This analysis is limited in 3 ways. First, the sample described is small. Second, the results may be confounded by the fact that each patient was on other systemic therapies in addition to TSEB, albeit stable pre-existing regimens. The time interval between completion of TSEB therapy and repetition of flow cytometry was not standardized among patients, which may result in an underestimation of the overall response to TSEB therapy.
CONCLUSION:
In patients with advanced mycosis fungoides and Sézary syndrome, the peripheral blood tumor burden may improve after treatment with TSEB.
AuthorsRachel S Klein, James D Dunlop, Sara S Samimi, Kelly A Morrissey, Katherine G Evans, Jennifer M Gardner, Camille E Introcaso, Carmela C Vittorio, Alain H Rook, Bizhan Micaily, Ellen J Kim
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 68 Issue 6 Pg. 972-7 (Jun 2013) ISSN: 1097-6787 [Electronic] United States
PMID23415461 (Publication Type: Journal Article)
CopyrightCopyright © 2012 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Topics
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • Combined Modality Therapy
  • Disease Progression
  • Flow Cytometry
  • Humans
  • Lymphocyte Count
  • Mycosis Fungoides (pathology, radiotherapy)
  • Prognosis
  • Radiotherapy (methods)
  • Radiotherapy Dosage
  • Sezary Syndrome (pathology, radiotherapy)
  • Skin Neoplasms (pathology, radiotherapy)
  • Treatment Outcome
  • Tumor Burden
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: